Category: Gastroenterology and Endoscopy

AI-assisted colonoscopy leads to higher benign lesion removal rates: Study

AI-assisted colonoscopies are associated with high detection and removal rates of non-neoplastic lesions, according to a new study presented at the American College of Gastroenterology’s 2024 Annual Scientific Meeting.

10 numbers scaring gastroenterologists 

Here are 10 numbers making gastroenterologists nervous right now:

5 new statistics on colonoscopy

Here are five key statistics on colonoscopies published in the last month:

5 colonoscopy malpractice cases to know 

Colonoscopies are often the subject of malpractice cases for gastroenterologists, according to a blog post from law firm Miller & Zois. 

UPMC Western Maryland expands GI care

Cumberland-based UPMC Western Maryland has expanded access to gastroenterology for patients through the addition of two new providers, according to an Oct. 29 report from the Cumberland Times-News.

Colonoscopy outpaces blood tests at cancer detection

While patients have new screening options for colorectal cancer, including stool and blood-based tests, studies have warned that blood tests are not as effective at detecting and preventing colon cancer. 

Cutting GI's CO2 footprint at no cost to patient care: 8 things to know

Ramjohan Rammohan, MD, a gastroenterology fellow at Nassau University Medical Center in East Meadow, N.Y., led a two-phase study of endoscopic procedures performed at the facility over one year and reported its findings at the American College of Gastr…

Mortality rates for early-onset CRC on the rise: 8 things to know

The mortality rate of early-onset colorectal cancer has increased over the last two decades, with those aged 20-44 years experiencing the most pronounced impact, Medscape Medical News reported Oct. 27.

Dartmouth Health GI department gets $14M gift

Lebanon, N.H.-based Dartmouth Health and the Geisel School of Medicine at Dartmouth have received a $14 million donation to improve digestive health services at Dartmouth Health’s Dartmouth Hitchcock Medical Center. 

Researchers link placebos to potential harm in IBD trials: 10 things to know

Two reviews of recent trials for drugs used to treat inflammatory bowel disease found that patients who received a placebo were at “significantly higher risk” for potential harms, MedPage Today reported Sept. 26.